First-Ever Dual Vaccine for Lassa Virus and Rabies Deemed Safe in Human Trial

discovermagazine - Learn more about Lassa virus, which continues to ravage parts of West Africa, and how combining a vaccine against it with rabies protection could address two major health concerns at once.

AI Summary: A first-in-human phase 1 trial of an adjuvanted, inactivated rabies virus–vectored Lassa vaccine met safety and tolerability endpoints in healthy adults, generating immune responses that support further development. The combined platform aims to protect against both Lassa fever and rabies, advancing toward larger trials and evaluation in regions where both diseases are endemic.